-
Mashup Score: 6
In the STOP-ACEi trial, the outcome was similar whether or not renin–angiotensin system inhibitors (RASi) were discontinued. We now investigate whethe…
Source: www.sciencedirect.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 41
Objectives. This study was performed to the efficacy, safety and clinical consequences of abrupt cessation of quinapril therapy in a placebo-controlle…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Withdrawal of #GDMT in HF consistently ➡️adverse clinical course⚠️ #ACEi in HFrEF (#QuinaprilHeartStudy) https://t.co/9AsSNhBxAv #SGLT2i in HF (#EMPEROR) https://t.co/Z6FPyhABjs #MRA in HFmrEF/HFpEF (tested in #FINEARTS) #GDMT in HFimpEF DCM (#TREDHF) https://t.co/oKGUIWqjXB https://t.co/JJz252EpAL https://t.co/39HPhyZHjw
-
-
Mashup Score: 2Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals - 1 year(s) ago
This cohort study assesses quality of care and clinical outcomes for US patients hospitalized for heart failure at rural vs urban hospitals in the Get With The Guidelines–Heart Failure registry.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
In this large contemporary cohort of US patients hospitalized for HF, patients at rural hospitals were less likely to receive multiple elements of guideline-directed HF care, such as #CRT, #ACEI/#ARB, and #ARNI therapies https://t.co/ncIVNV8q5r #HeartFailure @JAMACardio… https://t.co/JWtKHGtCv3 https://t.co/kEzYM6JqMx
-
-
Mashup Score: 1Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors - 1 year(s) ago
Data on angioedema risk among sacubitril-valsartan (SV) users in real-world settings are limited.We sought to evaluate the risk of angioedema among SV…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
🔥 In this 🇺🇸 study a strategy based on direct start of #ARNI vs the “switching strategy from an #ACEi/#ARB” resulted in a significantly ⬇️ of #angioedema 👉 #ARNI immediate start not only is more effective but also safer 🍀 @gcfmd @JJheart_doc @iamritu https://t.co/tFywymYdMi https://t.co/k3ck77xivT
-
-
Mashup Score: 9Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors: - 1 year(s) ago
Abstract Background Data on angioedema risk among sacubitril-valsartan (SV) users in real-world settings are limited. Objectives We sought to evaluate the risk of angioedema among SV new users comp…
Categories: Cardiologists, Latest HeadlinesTweet-
Comparative Risk of Angioedema With Sac/Val vs #RAAI This study did not observe increased angioedema risk for Sac/Val users compared with #ACEI users, and there was no difference in risk when Sac/Val users were compared with #ARB users https://t.co/nuH0qtuab5 @JACCJournals https://t.co/bB7Uxkyw39 https://t.co/98fnhhV1gI
-
-
Mashup Score: 0
In clinical trials, sacubitril/valsartan has demonstrated significant survival benefits compared to angiotensin converting enzyme inhibitors or angiot…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Sa/Val Vs ACEI/ARB at hospital discharge and 5-yr survival in older patients with #HFrEF The benefit of Sa/val over #ACEI/#ARB did not decrease with increasing age – NNT to treat among 66 to 74-yr-old patients was 84 and among 85+ year-old pts was 67 https://t.co/CFxru2w0np
-
-
Mashup Score: 1BBs, ACEI/ARBs to Prevent LV Dysfunction Due to Breast Cancer Drugs - American College of Cardiology - 2 year(s) ago
Salim Hayek, MD, FACC
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
In the primary analysis, #ACEI/ARB therapy was not associated with improved LVEF irrespective of concomitant #anthracycline or #trastuzumab therapy #BB therapy preserved LVEF significantly better compared with placebo #HeartFailure #CardioOnco @ACCinTouch https://t.co/WxzzmD8ntg
-
-
Mashup Score: 8Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition - 2 year(s) ago
BACKGROUND: The cardiorenal effects of sodium-glucose cotransporter 2 inhibition (empagliflozin 25 mg QD) combined with angiotensin-converting enzyme inhibition (ramipril 10 mg QD) were assessed in t
Source: CirculationCategories: Cardiologists, Latest HeadlinesTweet-
Renal and Vascular Effects of Combined #SGLT2i and #ACEI This first mechanistic trial that evaluated the effect of adding #SGLT2i to #ACEI on physiologic effects https://t.co/wHCrYmfQob @CircAHA @JamalRanaMD @AndrewJSauer @ErinMichos @DrMarthaGulati @mvaduganathan @JavedButler1 https://t.co/YZW1ZRDRr9
-
-
Mashup Score: 0
New kidney research from the University of Virginia School of Medicine is raising concerns that long-term use of drugs commonly prescribed to treat high-blood pressure and heart failure could be contributing to kidney damage.
Source: News-Medical.netCategories: Healthcare Professionals, Latest HeadlinesTweet-
Nota bene: https://t.co/qK7pJ8bx6F #ARB #ACEi #bloodpressure
-
-
Mashup Score: 4
Combined inhibition of NEP (neutral endopeptidase) and ACE (angiotensin-converting enzyme), without unwanted effects, remains an attractive therapeutic strategy in cardiovascular medicine. Omapatrila
Source: HypertensionCategories: Cardiology News and Journals, Latest HeadlinesTweet-
C-domain-specific #ACEi combined with #NEPi lowers #BP and improves #VascularFunction #Hypertension comparable to omapatrilat, but without increasing #VascularPermeability. @guto_montezano @fjorios @LabTouyz https://t.co/l7jpJo1D1K https://t.co/88h1MWSnxn
-
Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive #CKD https://t.co/LYYy8Ui6kr @HullHospitals @uhbtrust @SheffieldHosp #angiotensinreceptorblocker #ACEi https://t.co/5iPKqu72GS